Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: Evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis

被引:59
作者
Auernhammer, CJ [1 ]
Melmed, S [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Res Inst, Los Angeles, CA 90048 USA
关键词
D O I
10.1210/en.140.4.1559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We recently characterized leukemia inhibitory factor (LIF) as an important modulator of hypothalamo-pituitary-adrenal (HPA) axis activity. We now describe the role of interleukin (IL)-11, another member of the IL-6 cytokine family, in the neuro-immuno-endocrine modulation of the HPA axis. In murine hypothalamus, pituitary and corticotroph AtT-20 cells, IL-11 messenger RNA (mRNA) was detectable by RT-PCR only, whereas IL-11R mRNA transcripts were demonstrated by Northern blot. Using RT-PCR, IL-11 and IL-11R gene expression were also detected in normal human pituitaries, as well as in corticotropic and nonfunctioning pituitary adenomas. Incubation of AtT-20 cells for 24 h with 10(-9) M IL-11 stimulated ACTH secretion 1.4 +/- 0.1-fold (P < 0.01), whereas LIF at the same concentration caused a 1.5 +/- 0.1-fold increase (P < 0.001). POMC mRNA expression was induced by IL-11 (0.5 x 10(-9) M) and LIF (0.5 x 10(-9) M) 1.5 +/- 0.18-fold (P < 0.05) and 1.7 +/- 0.18-fold (P < 0.01), respectively. POMC promoter activity, assayed by a -706/+64 rat POMC promoter-luciferase construct, was stimulated by 0.5 x 10(-9) M IL-11 (1.9 +/- 0.06-fold; P < 0.001) and 5 mM Bu(2)cAMP (7.1 +/- 0.52-fold, P < 0.001), and combined treatment of IL-11 plus Bu(2)cAMP caused a synergistic 11.7 +/- 0.71-fold increase of luciferase activity (P < 0.001 vs. Bu(2)cAMP alone). Gene expression of SOCS-3, an intracellular inhibitor of cytokine action, peaked as early as 60 min after incubation with IL-11 (0.5 x 10(-9) M) and was induced 3.5-fold. In comparison to mock-transfected AtT-20 cells (AtT-20M), stable overexpression of SOCS-3 (AtT-20S) resulted in significant inhibition of ACTH secretion induced by IL-11 alone (1.5 +/- 0.09 vs. 1.1 +/- 0.04-fold induction, P < 0.01) and IL-11 plus Bu(2)cAMP (2.1 +/- 0.21 vs. 1.5 +/- 0.06-fold, P < 0.05), but not by Bu(2)cAMP alone (1.5 +/- 0.12 vs. 1.4 +/- 0.06). In summary, human and murine pituitary express IL-11 and IL-11R transcripts. In murine corticotroph AtT-20 cells, IL-11 induces POMC gene transcription and ACTH secretion. IL-11 induction of SOCS-3 indicates an intracellular negative feedback control of cytokine-induced POMC expression and ACTH secretion. Thus, IL-11 regulates the HPA axis similarly to LIF, providing further evidence for a redundant cytokine network in the neuro-immuno-endocrine regulation of the HPA axis.
引用
收藏
页码:1559 / 1566
页数:8
相关论文
共 40 条
[1]   HUMAN AND MURINE PITUITARY EXPRESSION OF LEUKEMIA INHIBITORY FACTOR - NOVEL INTRAPITUITARY REGULATION OF ADRENOCORTICOTROPIN HORMONE SYNTHESIS AND SECRETION [J].
AKITA, S ;
WEBSTER, J ;
REN, SG ;
TAKINO, H ;
SAID, J ;
ZAND, O ;
MELMED, S .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :1288-1298
[2]   Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function - A model for human pituitary Rathke's cysts [J].
Akita, S ;
Readhead, C ;
Stefaneanu, L ;
Fine, J ;
TampanaruSarmesiu, A ;
Kovacs, K ;
Melmed, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2462-2469
[3]   Cytokine expression and molecular mechanisms of their auto/paracrine regulation of anterior pituitary function and growth [J].
Arzt, E ;
Pereda, MP ;
Costas, M ;
Sauer, J ;
Renner, U ;
Holsboer, F ;
Stalla, GK .
NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 :525-531
[4]   Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary-adrenal axis [J].
Auernhammer, CJ ;
Chesnokova, V ;
Melmed, S .
ENDOCRINOLOGY, 1998, 139 (05) :2201-2208
[5]   Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion [J].
Auernhammer, CJ ;
Chesnokova, V ;
Bousquet, C ;
Melmed, S .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) :954-961
[6]   Six different cytokines that share GP130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamus-pituitary-adrenal axis by interleukin-1 [J].
Benigni, F ;
Fantuzzi, G ;
Sacco, S ;
Sironi, M ;
Pozzi, P ;
Dinarello, CA ;
Sipe, JD ;
Poli, V ;
Cappelletti, M ;
Paonessa, G ;
Pennica, D ;
Panayotatos, N ;
Ghezzi, P .
BLOOD, 1996, 87 (05) :1851-1854
[7]   Immune-neuro-endocrine interactions: Facts and hypotheses [J].
Besedovsky, HO ;
DelRey, A .
ENDOCRINE REVIEWS, 1996, 17 (01) :64-102
[8]   Two differentially expressed interleukin-11 receptor genes in the mouse genome [J].
Bilinski, P ;
Hall, MA ;
Neuhaus, H ;
Gissel, C ;
Heath, JK ;
Gossler, A .
BIOCHEMICAL JOURNAL, 1996, 320 :359-363
[9]  
Bousquet C, 1997, J BIOL CHEM, V272, P10551
[10]   SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION [J].
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1351-1362